In the fast-paced world of biotechnology and drug discovery, the reliability of your data is only as good as the tools you use. Whether you are identifying a novel biomarker, developing a therapeutic antibody, or conducting routine protein analysis, the reagents and assays in your lab form the bedrock of your scientific integrity. Creative Biolabs, a leader in antibody and protein engineering,...
The human microbiome is often referred to as our "forgotten organ," a complex ecosystem of trillions of microbes that influence everything from metabolic health to mental well-being. As researchers strive to decode the intricate dialogues between host and microbe, the demand for high-precision analytical tools has never been greater. Central to this quest are specialized antibodies that allow...
For decades, translational medicine has faced a frustrating bottleneck: why do over 90% of oncology and neurology drug candidates that show dazzling success in preclinical lab testing ultimately fail when injected into human patients? The answer lies in the structural limitations of our screening models. Traditional 2D cell monolayers flat-line the natural three-dimensional spatial architecture...
Antibody-Drug Conjugates (ADCs) have revolutionized oncology, earning their reputation as biological "Trojan horses." By tethering a highly potent cytotoxic payload to a target-specific monoclonal antibody, ADCs promise to deliver chemotherapy directly to malignant cells while sparing healthy tissues.
However, translating this elegant concept into a safe, clinically viable therapeutic is...
For decades, Immunoglobulin G (IgG) has been the undisputed protagonist of biomedical research and therapeutic development. Its stability and abundance in mammalian serum have made it the "gold standard" for everything from diagnostic assays to monoclonal antibody therapies. However, as the complexity of modern medicine increases, researchers are discovering that the standard IgG format...
For decades, neuroscientists viewed the human brain as an isolated command center, shielded from the rest of the body by the formidable blood-brain barrier. However, groundbreaking research over the last decade has shattered this insular perspective, revealing a highly dynamic and bidirectional communication network known as the brain-gut-immune axis.
At the heart of this complex network is the...
In the last decade, the biological sciences have undergone a paradigm shift. We have moved from “bulk” sequencing—where the average signal of thousands of cells masks the unique contributions of individuals—to the high-definition world of single-cell analysis. However, as our understanding of cellular heterogeneity deepens, researchers are realizing that looking at the...
Q1: What types of biomarkers can be detected using your biosensor platforms? A: Our platform is highly versatile and can be customized to detect a wide range of disease biomarkers, including specific proteins, nucleic acids, metabolites, and even whole cells, offering exceptional sensitivity and rapid response times.
Q2: How does your team support the development of these diagnostic...
Date: August 11, 2026
Time: 11:00 AM – 12:00 PM EDT
Featured Guest Speaker: Dr. Ivelin Georgiev
Monoclonal antibodies stand out as highly powerful preventive and therapeutic modalities against complex infectious diseases, diverse cancers, and autoimmune conditions. However, conventional antibody discovery workflows continue to hit a wall. Biopharma teams routinely...
Q1: Why is it necessary to evaluate the environmental persistence of live biotherapeutics? A: Assessing environmental persistence is a critical regulatory requirement. It ensures that genetically modified or therapeutically enhanced live microbes do not pose unintended colonization, contamination, or biosafety risks when shed into the environment.
Q2: What methodologies do you use to...
Q1: What methods are used to induce corneal wounds in your animal models? A: We utilize well-established and highly reproducible methods, such as mechanical scraping of the epithelium or chemical injury (e.g., alkali burns). This allows us to accurately replicate clinical corneal defects and stromal injuries based on your specific study requirements.
Q2: How do you monitor the wound...
Q1: What specific safety aspects are evaluated for exosomes intended for cosmetic use? A: We conduct a comprehensive range of assessments, including in vitro cytotoxicity, skin irritation, ocular irritation, sensitization, and microbiological testing, to ensure that the exosomes meet strict global cosmetic safety standards.
Q2: How do you test for skin irritation without using animal...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek